IP Library Granted Patent US 9,839,232
Granted Patent B2
US 9,839,232 · App. 14/612,847 · Granted Dec 12, 2017

Stable thickener formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,232
App. No.
14/612,847
Granted
Dec 12, 2017
Kind
B2
Abstract

Stable thickener formulations and nutritional compositions having the stable thickener formulations are provided. In a general embodiment the present disclosure provides a stable thickener formulation comprising from about 0.015% to about 0.05% by weight of carrageenan and from about 1.2% to about 4.0% by weight of starch. The stable thickener formulation can be used in nutritional compositions used to treat a variety of physiological conditions.

Claims (21)

1. A method for treating a medical condition selected from the group consisting of dysphagia, renal failure, chronic obstructive pulmonary disorders, malabsorption disorders, post-stroke, and combinations thereof in a patient, the method comprising administering to the patient a composition including a stable thickener formulation having a viscosity from about 1100 cps to about 9000 cps and selected from the group of:

from about 0.03% to about 0.05% by weight of carrageenan and from about 1.5% to about 4.0% by weight of starch, and at least one nutritional ingredient, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof; and

a weight of carrageenan and a weight of starch in a ratio of about 1:69 to about 1:122, and at least one nutritional ingredient, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof.

2. The method of claim 1 , wherein the medical condition is dysphagia.

3. The method of claim 1 , wherein the medical condition is renal failure.

4. The method of claim 1 , wherein the medical condition is a chronic obstructive pulmonary disorder.

5. The method of claim 1 , wherein the medical condition is a malabsorption disorder.

6. The method of claim 1 , wherein the medical condition is post-stroke.

7. The method of claim 1 , wherein the patient is an elderly person.

8. A method for providing nutrition to a patient with dysphagia comprising administering to the patient a composition including a stable thickener formulation having a viscosity from about 1100 cps to about 9000 cps and selected from the group consisting of:

from about 0.03% to about 0.05% by weight of carrageenan and from about 1.5% to about 4.0% by weight of starch, and at least one nutritional ingredient, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof; and

a weight of carrageenan and a weight of starch in a ratio of about 1:69 to about 1:122, and at least one nutritional ingredient, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof.

9. The method of claim 8 , wherein the patient has a medical condition.

10. The method of claim 9 , wherein the medical condition is selected from the group consisting of renal failure, chronic obstructive pulmonary disorders, malabsorption disorders, post-stroke, and combinations thereof.

11. The method of claim 9 , wherein the medical condition is renal failure.

12. The method of claim 9 , wherein the medical condition is a chronic obstructive pulmonary disorder.

13. The method of claim 9 , wherein the medical condition is a malabsorption disorder.

14. The method of claim 9 , wherein the medical condition is post-stroke.

15. The method of claim 8 , wherein the patient is an elderly person.

16. The method of claim 1 , wherein the carrageenan and the starch are present in the formulation in a weight ratio of about 1:75 to about 1:110.

17. A method for treating a medical condition selected from the group consisting of dysphagia, renal failure, chronic obstructive pulmonary disorders, malabsorption disorders, post-stroke, and combinations thereof in a patient, the method comprising administering to the patient a composition including a stable thickener formulation comprising carrageenan, starch and at least one nutritional ingredient, the viscosity of the formulation is from about 300 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof, wherein the carrageenan is present in the formulation in an amount about 0.04% by weight and the starch is present in the formulation in an amount about 3.54% by weight.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: OLSON, ERIN
To: NESTEC S.A.
Reel/Frame 035637/0846 →